Gilead Sciences Inc. (GILD) News Headlines

▮ More

Date

Headline

11/20/2020 1:47:38 AM WHO Recommends Against Using Gilead Sciences' Remdesivir For Covid

11/20/2020 1:46:37 AM AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B

11/20/2020 12:51:30 AM WHO Recommends Against Use Of Remdesivir In Hospitalized COVID-19 Patients

11/19/2020 11:04:01 PM FDA Issues Emergency Approval To Lilly's Arthritis Drug With Remdesivir For COVID-19 Treatment

11/18/2020 9:29:27 AM Gilead Sciences' Lenacapavir Meets Primary Endpoint In Phase 2/3 HIV Study

11/18/2020 8:37:56 AM Gilead Says Lenacapavir Achieves Primary Endpoint In Phase 2/3 Study

11/16/2020 2:18:13 AM New Drugs Approved In October

11/9/2020 10:38:24 PM Lilly's COVID-19 Antibody Drug Gets FDA Emergency Use Authorization For Non-hospitalized Patients

11/5/2020 9:05:56 AM Gilead, Kite To Share Latest Scientific Advances In Hematologic Malignancies At ASH 2020

10/28/2020 5:20:49 PM Gilead Sciences Inc. (GILD) Has Lowered Its 2020 EPS Estimate To 6.25 - 6.60 From 6.25 - 7.65

10/28/2020 5:19:22 PM Gilead Sciences Inc. Q3 adjusted earnings of $2.11 per share

10/28/2020 5:12:50 PM Gilead Sciences Inc. (GILD) Declares $ 0.68 Dividend for Q4 20, Record Date 12/15/2020

10/28/2020 4:32:07 PM Gilead Sciences Swings To Q3 Profit

10/28/2020 4:06:10 PM Gilead Sciences Declares Quarterly Dividend Of $0.68/share, Payable Dec. 30/ Record Dec. 15

10/28/2020 4:05:09 PM Gilead Sciences Q3 GAAP EPS $0.29 Vs Loss $0.92 Last Year

10/28/2020 3:02:39 PM Gilead Sciences Q3 20 Earnings Conference Call At 4:30 PM ET

10/26/2020 11:04:29 PM Eli Lilly Ends Late-stage Covid-19 Antibody Trial In U.S. Due To Insufficient Data

10/26/2020 1:45:58 AM Biotech Stocks Facing FDA Decision In November 2020

10/23/2020 10:12:54 AM Stock Alert: Gilead Sciences Shares Up 3%

10/23/2020 9:28:33 AM Gilead Completes Transaction To Acquire Immunomedics - Quick Facts